Access cutting-edge high-grade glioma treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access high-grade glioma specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related high-grade glioma treatment provided free
The goal of this interventional study is to evaluate the efficacy of APG-157 in combination with Bevacizumab in subjects with recurrent high-grade glioma. The main questions the study aims to answer are: * Progression-free and overall survival of patients receiving this combination; * Quality of Life (QOL); and * Tumor response on imaging The participants will take APG-157 daily by dissolving two pastilles in their mouth at around breakfast, lunch and dinner time (total of six pastilles per da
Sponsor: Aveta Biomics, Inc.
Check if you qualify for this high-grade glioma clinical trial in Rochester, MN
If you're searching for high-grade glioma treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high-grade glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.